PMVP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
PMV Pharmaceuticals Inc (PMVP) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. While hedge funds have shown significant interest, the lack of positive financial performance, absence of recent news or catalysts, and weak technical indicators suggest that this stock does not currently present a compelling long-term investment opportunity.
The MACD is positive but contracting, RSI is neutral at 60.956, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level (1.426) but has not broken key resistance levels (R1: 1.754). Overall, the technical indicators suggest a neutral outlook.
Hedge funds are significantly increasing their positions, with a 2450.33% increase in buying activity over the last quarter.
No recent news or event-driven catalysts. Insider trading activity is neutral, and there is no recent trading activity from Congress or influential figures. The stock has a 70% chance of declining over the next month (-6.15%).
In Q3 2025, the company reported no revenue growth (0% YoY), a net income loss of -$21.059 million (up 9.53% YoY), and an EPS of -0.4 (up 8.11% YoY). Despite slight improvements in net income and EPS, the company remains unprofitable with no revenue growth.
No recent analyst ratings or price target changes are available for PMVP.
